FDA Announces Resolution Of Pfizer Solu-Medrol Shortage
This article was originally published in The Pink Sheet Daily
The American Society of Health-System Pharmacists states that hospitals no longer need prior approval for all orders but institutions should consider conserving supplies of methylprednisolone injection for critical indications.
You may also be interested in...
Company has overcome “supply and demand” problems and is now stocked with 40 mg and 125 mg vials of the injectable anti-inflammatory.
Amended application includes 50 mg and 100 mg dosage forms, which are used in multiple myeloma.